PCOS is associated with a pro-inflammatory state and Ras proteins are involved in regulating inflammatory responses, with activation of Ras contributing to the chronic low-grade inflammation seen in PCOS patients; KRAS is a potential pharmacological target to treat PCOS [9]. This evidence concerns the gene KRAS and polycystic ovary syndrome.